Summary:
Patients will be randomized 1:1:1 ratio to either the test product, reference product or placebo. Subjects must have a presence of moderate facial rosacea with at least moderate persistent erythema.
The facial product is applied twice daily in the morning and evenings.
Study is 12 weeks long. Visits are every 4 weeks. $50 compensation per visit.
Qualified Participants Must:
• Have a presence of moderate facial rosacea with at least moderate persistent erythema
Qualified Participants May Receive:
$50 Compensation per visit
Facial product to treat Rosacea